CORBUS PHARMACEUTICALS HOLDI

Ben Yong Sells 2,000 Corbus Shares Amid Slumping Stock and Uncertain Weight‑Loss Pipeline Flash.

Ben Yong’s 2,000‑share sale of Corbus Pharma shares signals a personal liquidity move, not a bearish warning—watch insider trades and upcoming trial data for clues on the company’s pipeline.

CORBUS PHARMACEUTICALS HOLDI
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

15/09/2026, 23:15

3 minutes to read

Corbus Pharma Rewards CMO with Zero‑Cost RSU & Option Awards Amid Executive Sell‑Offs, Hinting at Confidence in Lenabasum Pipeline

Corbus Pharmaceuticals’ insider moves show CMO Nicacio Viana’s new RSU and option grants signal strong confidence in the company’s lenabasum pipeline and future growth.

CORBUS PHARMACEUTICALS HOLDI
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

17/08/2026, 22:47

3 minutes to read